Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema

NCT00886808 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Diabetic Macular Edema

Interventions

DRUG: iCo-007 Intravitreal Injection

Sponsor

iCo Therapeutics Inc.